Intralesional corticosteroid administration in the treatment of keloids: a survey among Dutch dermatologists and plastic surgeons

References

• Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):606.
   PubMed Web of Science ®Google Scholar
• Furtado F, Hochman B, Ferrara SF, et al. What factors affect the quality of life of patients with keloids? Rev Assoc Med Bras (1992). 2009;55(6):700–704.
   PubMed Web of Science ®Google Scholar
• Bijlard E, Kouwenberg CA, Timman R, et al. Burden of keloid disease: a cross-sectional health-related quality of life assessment. Acta Derm Venereol. 2017;97(2):225–229.
   PubMed Web of Science ®Google Scholar
• Kassi K, Kouame K, Kouassi A, et al. Quality of life in Black African patients with keloid scars. Dermatol Reports. 2020;12(2):8312.
   PubMed Web of Science ®Google Scholar
• Wang CJ, Ko JY, Chou WY, et al. Extracorporeal shockwave therapy for treatment of keloid scars. Wound Repair Regen. 2018;26(1):69–76.
   PubMed Web of Science ®Google Scholar
• Kaushal V, Kumar S, Brar BK, et al. Comparative evaluation of therapeutic efficacy and safety of intralesional triamcinolone acetonide injection vs intralesional radiofrequency with intralesional triamcinolone acetonide in treatment of keloids. Dermatol Ther. 2020;33(6):e13919.
   PubMed Web of Science ®Google Scholar
• Callen JP. Intralesional corticosteroids. J Am Acad Dermatol. 1981;4(2):149–151.
   PubMed Web of Science ®Google Scholar
• Syed F, Bayat A. Superior effect of combination vs. monotherapy in keloid disease: a comparative in vitro analysis of glucocorticoids. Wound Repair Regen. 2012;20(2):A41.
   Web of Science ®Google Scholar
• Delaney TJ, Rowlingson JC, Carron H, et al. Epidural steroid effects on nerves and meninges. Anesth Analg. 1980;59(8):610–614.
   PubMed Web of Science ®Google Scholar
• Jarratt MT, Spark RF, Arndt KA. The effects of intradermal steroids on the pituitary–adrenal axis and the skin. J Invest Dermatol. 1974;62(4):463–466.
   PubMed Web of Science ®Google Scholar
• Muneuchi G, Suzuki S, Onodera M, et al. Long-term outcome of intralesional injection of triamcinolone acetonide for the treatment of keloid scars in Asian patients. Scand J Plast Reconstr Surg Hand Surg. 2006;40(2):111–116.
   PubMed Web of Science ®Google Scholar
• Usanakornkul A, Burusapat C. A topical anesthetic and lidocaine mixture for pain relief during keloid treatment: a double-blind, randomized controlled trial. Dermatol Surg. 2017;43(1):66–73.
   PubMed Web of Science ®Google Scholar
• Jongkajornpong N, Wattanawong K. The efficacy of skin cooling for pain relief during intralesional steroid injection for keloid treatment: a randomized cross-over study. J Med Assoc Thailand. 2021;104(11):1752–1757.
   Google Scholar
• Wang X, Wu X, Liu K, et al. Topical cryoanesthesia for the relief of pain caused by steroid injections used to treat hypertrophic scars and keloids. Medicine. 2017;96(43):e8353.
   PubMed Web of Science ®Google Scholar
• Ono N. Pain-free intralesional injection of triamcinolone for the treatment of keloid. Scand J Plast Reconstr Surg Hand Surg. 1999;33(1):89–91.
   PubMed Web of Science ®Google Scholar
• Aluko-Olokun B, Olaitan AA, Ladeinde AL, et al. Determination of the optimal frequency of injection of triamcinolone: monitoring change in volume of keloid lesions following injection of 40 mg of triamcinolone. Eur J Plast Surg. 2016;39(2):119–124.
   Google Scholar
• Vo A, Doumit M, Rockwell G. The biomechanics and optimization of the needle-syringe system for injecting triamcinolone acetonide into keloids. J Med Eng. 2016;2016:5162394.
   PubMedGoogle Scholar
• Benzon HT, Chew TL, McCarthy RJ, et al. Comparison of the particle sizes of different steroids and the effect of dilution: a review of the relative neurotoxicities of the steroids. Anesthesiology. 2007;106(2):331–338.
   PubMed Web of Science ®Google Scholar
• Tiso RL, Cutler T, Catania JA, et al. Adverse central nervous system sequelae after selective transforaminal block: the role of corticosteroids. Spine J. 2004;4(4):468–474.
   PubMedGoogle Scholar
• Jiao H, Zhang T, Fan J, et al. The superficial dermis may initiate keloid formation: histological analysis of the keloid dermis at different depths. Front Physiol. 2017;8:885.
   PubMed Web of Science ®Google Scholar
• Syed F, Ahmadi E, Iqbal SA, et al. Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy. Br J Dermatol. 2011;164(1):83–96.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Akita S, Akaishi S, et al. Diagnosis and treatment of keloids and hypertrophic scars—Japan Scar Workshop Consensus Document 2018. Burns Trauma. 2019;7:39.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Tosa M, Dohi T, et al. Keloids and hypertrophic scars can be cured completely. Wound Repair Regen. 2019;27(5):A2.
   Web of Science ®Google Scholar
• Lumenta DB, Siepmann E, Kamolz LP. Internet-based survey on current practice for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids. Wound Repair Regen. 2014;22(4):483–491.
   PubMed Web of Science ®Google Scholar